+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cerebral Palsy"

From
From
Neurorehabilitation Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Neurorehabilitation Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
From
Global Neurological Therapies Growth Opportunities - Product Thumbnail Image

Global Neurological Therapies Growth Opportunities

  • Report
  • October 2021
  • 61 Pages
  • Global
From
From
Loading Indicator

Cerebral Palsy (CP) is a neurological disorder that affects movement, posture, and coordination. It is caused by damage to the developing brain, usually before or during birth. CP is a lifelong condition that can range from mild to severe, and can affect physical, cognitive, and social functioning. The therapeutic area for CP is focused on improving the quality of life for those affected. Treatment options include physical, occupational, and speech therapy, as well as medications, assistive devices, and surgery. There is also a focus on providing support and education to families and caregivers. Companies in the CP market include AbbVie, Biogen, GlaxoSmithKline, Novartis, Pfizer, and Sanofi. These companies are involved in the development of medications, therapies, and assistive devices to help those with CP. Show Less Read more